Ju Fu Tang Biotech Holdings Co (HKSE:08217) ROCE %: 9.03% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:08217 Ju Fu Tang Biotech Holdings Co Ltd HKSE:08217
36 GF Score
Price HK$0.11
GF Value HK$0.15
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Ju Fu Tang Biotech Holdings Co ROCE %?

Ju Fu Tang Biotech Holdings Co HKSE:08217 -3.60% 36 ROCE % is 9.03% as of Mar. 2026. GuruFocus rates HKSE:08217 with a GF Score™ of 36/100 and a GF Value™ of HK$0.15 (Modestly Undervalued). The stock has 4 warning signs investors should review.

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Ju Fu Tang Biotech Holdings Co's annualized ROCE % for the quarter that ended in Mar. 2026 was 9.03%.

Ju Fu Tang Biotech Holdings Co  (HKSE:08217) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Ju Fu Tang Biotech Holdings Co ROCE % Related Terms

Ju Fu Tang Biotech Holdings Co ROCE % Historical Data

* Premium members only.

The historical data trend for Ju Fu Tang Biotech Holdings Co's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ju Fu Tang Biotech Holdings Co ROCE % Chart

Ju Fu Tang Biotech Holdings Co Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
ROCE %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -39.95 -16.64 -39.95 -17.17 61.83

Ju Fu Tang Biotech Holdings Co Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
ROCE % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 15.99 -28.20 -6.05 114.92 9.03
HKSE:08217
36GF Score
Ju Fu Tang Biotech Holdings Co Ltd HKSE:08217
ROCE % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Ju Fu Tang Biotech Holdings Co ROCE % Calculation

Ju Fu Tang Biotech Holdings Co's annualized ROCE % for the fiscal year that ended in Mar. 2026 is calculated as:

ROCE %=EBIT/( (Capital Employed+Capital Employed)/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(A: Mar. 2026 )  (A: Mar. 2025 )(A: Mar. 2026 )
=24.038/( ( (80.365 - 53.147) + (92.61 - 42.075) )/ 2 )
=24.038/( (27.218+50.535)/ 2 )
=24.038/38.8765
=61.83 %

Ju Fu Tang Biotech Holdings Co's ROCE % of for the quarter that ended in Mar. 2026 is calculated as:

ROCE %=EBIT (1)/( (Capital Employed+Capital Employed)/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=EBIT/( ( (Total Assets - Total Current Liabilities)+(Total Assets - Total Current Liabilities) )/ count )
(Q: Mar. 2026 )  (Q: Sep. 2025 )(Q: Mar. 2026 )
=4.478/( ( (98.96 - 50.303) + (92.61 - 42.075) )/ 2 )
=4.478/( ( 48.657 + 50.535 )/ 2 )
=4.478/49.596
=9.03 %

(1) Note: The EBIT data used here is two times the semi-annual (Mar. 2026) EBIT data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about ROCE % →
What does a ROCE % of 9.03% mean?
Ju Fu Tang Biotech Holdings Co (HKSE:08217) has a ROCE % of 9.03% as of Mar. 2026.
Is Ju Fu Tang Biotech Holdings Co's ROCE % too high?
Ju Fu Tang Biotech Holdings Co's current ROCE % is 9.03%. The Construction industry median ROCE % is 8.22. Ju Fu Tang Biotech Holdings Co's value of 9.03% is 9.9% above this industry median. Overall, Ju Fu Tang Biotech Holdings Co has a GF Score™ of 36/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Ju Fu Tang Biotech Holdings Co's ROCE % compare to PWR and FIX?
Ju Fu Tang Biotech Holdings Co's ROCE % of 9.03% can be compared against companies in the Construction industry. The industry median ROCE % is 8.22. Ju Fu Tang Biotech Holdings Co's value of 9.03% is 9.9% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROCE % for a Construction company?
The median ROCE % among Construction companies is 8.22, based on 1,758 companies in the industry. Companies in the top quartile (top 25%) have a ROCE % significantly above this median, while those in the bottom quartile fall well below. However, ROCE % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Ju Fu Tang Biotech Holdings Co's current ROCE % of 9.03% is 9.9% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROCE % mean?
A high ROCE % can signal that a stock is expensive relative to its fundamentals. For the Construction industry, the median ROCE % is 8.22 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Ju Fu Tang Biotech Holdings Co's current ROCE % is 9.03%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Ju Fu Tang Biotech Holdings Co stock overvalued right now?
Based on GuruFocus' analysis, Ju Fu Tang Biotech Holdings Co (HKSE:08217) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$0.15, compared to a current price of HK$0.11 — trading 28.7% below its estimated fair value. The current ROCE % is 9.03% and 9.9% above the Construction industry median of 8.22. Ju Fu Tang Biotech Holdings Co's overall GF Score™ is 36/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROCE % calculated?
ROCE % is calculated from a company's financial statements. For Ju Fu Tang Biotech Holdings Co (HKSE:08217), the current ROCE % is 9.03% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Ju Fu Tang Biotech Holdings Co (HKSE:08217) Overvalued in 2026?

Based on GuruFocus' analysis, Ju Fu Tang Biotech Holdings Co stock appears to be undervalued. The current stock price of HK$0.11 is trading 28.7% below its estimated GF Value™ of HK$0.15. GuruFocus considers Ju Fu Tang Biotech Holdings Co to be Modestly Undervalued.

Key valuation signals for HKSE:08217:

  • ROCE %: 9.03%
  • GF Value™: HK$0.15 vs. price of HK$0.11 (28.7% below fair value)
  • GF Score™: 36/100 with 4 warning signs
  • Industry Position: 9.9% above the Construction median

No single metric tells the full story. See the HKSE:08217 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Ju Fu Tang Biotech Holdings Co Business Description

Address 489 Hennessy Road, Unit 2202, 22nd Floor, Causeway Bay Plaza I, Causeway Bay, Hong Kong, HKG
Ju Fu Tang Biotech Holdings Co Ltd, formerly known as WMHW Holdings Ltd, is an investment holding company operating through its subsidiaries. It engaged in the provision of construction works and investment holding.
36GF Score

Get the complete analysis for HKSE:08217

ROCE % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.11
Price
HK$0.15
GF Value